Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study - Report - MDSpire

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

  • By

  • Bassam Abdul Rasool Hassan

  • Ali Haider Mohammed

  • Khalis Mohamed

  • Vladimir Yu. Startsev

  • Chema Drira

  • Omar Hamdy

  • Miada Mohamed Fahmi Elmetwaly

  • Said Nabil

  • Shamma Alshehhi

  • Gamil Othman

  • Hamoud H. Y. Al-Hussaini

  • Ahmed Zuhair Abdulhameed Alsammarraie

  • Arooj Abid

  • Nada M. Kassem

  • Sami El Khatib

  • Souheil Hallit

  • Diana Malaeb

  • Hassan Hosseini

  • June 5, 2026

  • 0 min

Share

Clinical Report: Oncologists' Understanding of Chemotherapy Resistance

Overview

This study reveals significant gaps in oncologists' knowledge and practices regarding chemotherapy resistance, highlighting demographic factors influencing their understanding. Targeted educational interventions are recommended to improve management strategies in diverse clinical settings.

Background

Chemotherapy remains a cornerstone in cancer treatment, yet its effectiveness is often compromised by chemotherapy resistance, leading to treatment failures and increased mortality. Understanding oncologists' perspectives on this issue is crucial, as their knowledge and attitudes directly impact patient outcomes and treatment decisions.

Data Highlights

CharacteristicFinding
Mean Age of Participants36.92 ± 9.24 years
Percentage of Female Participants53.1%
Odds of Good Knowledge (Age ≥56)OR = 0.76
Odds of Good Knowledge (Female)OR = 1.22
Odds of Good Knowledge (Post-Doctorate)OR = 1.57

Key Findings

  • 3,779 oncologists participated in the study, with a mean age of 36.92 years.
  • 53.1% of participants were female, showing higher odds of good knowledge and positive attitudes.
  • Oncologists aged ≥56 years had lower odds of good knowledge (OR = 0.76).
  • Post-doctorate holders had greater odds of good knowledge (OR = 1.57) compared to those with only a medical bachelor's degree.
  • Longer professional experience and previous exposure to chemotherapy resistance cases were associated with better knowledge and attitudes.

Clinical Implications

The findings underscore the need for enhanced educational programs targeting oncologists, especially in regions with limited resources. Improving knowledge and attitudes towards chemotherapy resistance can lead to better patient management and outcomes.

Conclusion

Addressing the identified gaps in oncologists' understanding of chemotherapy resistance is essential for improving treatment strategies. Continuous professional development is vital for enhancing clinical preparedness in managing this complex issue.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Overcoming chemoresistance in esophageal cancer with synergistic strategies
  2. The ASCO Post, 2018 -- Expect Questions About Necessity of Chemotherapy for Early-Stage Breast Cancer
  3. Frontiers in Oncology, 2026 -- Breast cancer chemotherapy in transition: predictive markers, resistance mechanisms, and new treatment approaches
  4. Nature Reviews Clinical Oncology -- Understanding and overcoming multidrug resistance in cancer
  5. ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer - PubMed
  6. The ASCO Post — Two Studies Highlight Communication Challenges Facing Medical Oncology
  7. Understanding and overcoming multidrug resistance in cancer | Nature Reviews Clinical Oncology
  8. ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer - PubMed
  9. The efficacy and safety of mirvetuximab soravtansine for the treatment of recurrent ovarian cancer: an update systematic review and meta-analysis - PMC

Original Source(s)

Related Content